Investor relations just responded and said there have been 6 FDA approvals this year but none were material to warrant a market announcement. They do all look like commodity products but honestly, these could have been referred to in a COVID market update - "our business remains stable and our portfolio continues to grow with X new FDA approvals in the last X months." Seriously, how hard is it? Also asked re Nuvaring and if a site inspection is required... they said the feedback from the FDA re that was not clear at this point. Didn't sound negative, just general vague commentary.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)